Literature DB >> 17431811

Prevalence of self-reported interstitial cystitis (IC) and interstitial-cystitis-like symptoms among adult women in the community.

Ibrahim A Ibrahim1, Ananias C Diokno, Kim A Killinger, Donna J Carrico, Kenneth M Peters.   

Abstract

PURPOSE: Reported estimates of IC prevalence vary widely. The objective of this study is to determine the prevalence of IC among community-dwelling adult women.
METHODS: We analyzed survey responses from 215 established IC cases and 823 age-matched community-dwelling controls. Using a history of diagnosis of urinary conditions and presence of pelvic pain within the last six months, we identified those with possible IC among the controls using various operative definitions.
RESULTS: The prevalence rates of self-reported IC (SRIC) and IC-like symptoms (ICLS) among controls in the community were 3.7% and 4.4%, respectively. Expanding ICLS by including women who reported pelvic pain only raised the prevalence to 17.3%.
CONCLUSIONS: According to our prevalence rates and population estimates in the United States census 2000, the number of adult women who possibly have interstitial cystitis is estimated to be between 422,803 and 21,454,813. Although estimates based on the question of having ever been diagnosed with IC lead to an estimate close to that derived from symptoms, underestimation of IC prevalence might occur in the absence of additional questions and testing to validate and qualify the responses further. There is also a need for clinical studies to verify and validate the diagnoses to enable accurate assessment of the sensitivity and specificity of such history survey questions.

Entities:  

Mesh:

Year:  2007        PMID: 17431811     DOI: 10.1007/s11255-007-9181-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Prevalence of interstitial cystitis in young women.

Authors:  C Lowell Parsons; Vasiliki Tatsis
Journal:  Urology       Date:  2004-11       Impact factor: 2.649

2.  Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland.

Authors:  Mikael Leppilahti; Jukka Sairanen; Teuvo L J Tammela; Sirpa Aaltomaa; Kari Lehtoranta; Anssi Auvinen
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

3.  Prevalence of interstitial cystitis symptoms in a managed care population.

Authors:  J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe Rosetti; Sheila O Brown; Sara Y Gao; Elizabeth A Calhoun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

Review 4.  The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics.

Authors:  L J Simon; J R Landis; D R Erickson; L M Nyberg
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

5.  Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office.

Authors:  Matt T Rosenberg; Matthew Hazzard
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

6.  Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study.

Authors:  J Curtis Nickel; Joel M H Teichman; Mireille Gregoire; Janet Clark; Joe Downey
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

7.  Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity.

Authors:  C Lowell Parsons; Jeffrey Dell; Edward J Stanford; Michael Bullen; Bruce S Kahn; Tracy Waxell; James A Koziol
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

8.  Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland.

Authors:  Mikael Leppilahti; Teuvo L J Tammela; Heini Huhtala; Anssi Auvinen
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

9.  Epidemiology of interstitial cystitis: a population based study.

Authors:  G C Curhan; F E Speizer; D J Hunter; S G Curhan; M J Stampfer
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

  9 in total
  14 in total

1.  In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats.

Authors:  Robert E Hurst; Samuel Van Gordon; Karl Tyler; Bradley Kropp; Rheal Towner; HsuehKung Lin; John O Marentette; Jane McHowat; Ehsan Mohammedi; Beverley Greenwood-Van Meerveld
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

2.  Psychological distress in twins with urological symptoms.

Authors:  Lisa Johnson Wright; Carolyn Noonan; Sandra Ahumada; María Angeles Bullones Rodríguez; Dedra Buchwald; Niloofar Afari
Journal:  Gen Hosp Psychiatry       Date:  2010-02-20       Impact factor: 3.238

3.  Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.

Authors:  Yik N Lim; Peter Dwyer; Christine Murray; Debjyoti Karmakar; Anna Rosamilia; Elizabeth Thomas
Journal:  Int Urogynecol J       Date:  2016-12-16       Impact factor: 2.894

4.  Dissimilar effects of tolterodine on detrusor overactivity in awake rats with chemical cystitis and partial bladder outlet obstruction.

Authors:  Long-Hu Jin; Chang-Shin Park; Hwa-Yeon Shin; Sang-Min Yoon; Tack Lee
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

5.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

6.  Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis.

Authors:  Michael S Ingber; Kenneth M Peters; Kim A Killinger; Donna J Carrico; Ibrahim A Ibrahim; Ananias C Diokno
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-18

7.  Intravesical lignocaine in the diagnosis of bladder pain syndrome.

Authors:  Rajesh Taneja
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

8.  Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes.

Authors:  Mary P FitzGerald; Rodney U Anderson; Jeannette Potts; Christopher K Payne; Kenneth M Peters; J Quentin Clemens; Rhonda Kotarinos; Laura Fraser; Annemarie Cosby; Carole Fortman; Cynthia Neville; Suzanne Badillo; Lisa Odabachian; Andrea Sanfield; Betsy O'Dougherty; Rick Halle-Podell; Liyi Cen; Shannon Chuai; J Richard Landis; Keith Mickelberg; Ted Barrell; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2009-06-17       Impact factor: 7.450

9.  Life impact of urologic pain syndromes.

Authors:  Lena Hatchett; Mary Pat Fitzgerald; Jeannette Potts; Abigail Winder; Keith Mickelberg; Ted Barrell; John W Kusek
Journal:  J Health Psychol       Date:  2009-09

10.  Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes.

Authors:  Mary P Fitzgerald; Rodney U Anderson; Jeannette Potts; Christopher K Payne; Kenneth M Peters; J Quentin Clemens; Rhonda Kotarinos; Laura Fraser; Annemarie Cosby; Carole Fortman; Cynthia Neville; Suzanne Badillo; Lisa Odabachian; Andrea Sanfield; Betsy O'Dougherty; Rick Halle-Podell; Liyi Cen; Shannon Chuai; J Richard Landis; Keith Mickelberg; Ted Barrell; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2013-01       Impact factor: 7.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.